Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004257316 | SCV003883755 | uncertain significance | not specified | 2023-02-22 | criteria provided, single submitter | clinical testing | The c.13G>A (p.G5S) alteration is located in exon 1 (coding exon 1) of the NPC1L1 gene. This alteration results from a G to A substitution at nucleotide position 13, causing the glycine (G) at amino acid position 5 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |